James D. Neaton
ORCID：0000-0001-9986-069X
发表论文 371 篇 · 总被引 55713 次 · h-index 93
代表论文
- Remdesivir for the Treatment of Covid-19 — Final Report (2020 · New England Journal of Medicine · 被引 7757)
- Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial (2022 · UCL Discovery (University College London) · 被引 192)
- Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial (2019 · The Lancet Respiratory Medicine · 被引 135)
- Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial (2022 · The Lancet Respiratory Medicine · 被引 130)
- The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 (2022 · Annals of Internal Medicine · 被引 63)
- Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3) (2021 · Clinical Trials · 被引 33)